Zelnecirnon clinical trials
Also written RPT193.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How each study uses zelnecirnon is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- RPT193
- 3
Studies by the year they started
3 studies that test it; most in 2019 (1)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses zelnecirnon is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- An Efficacy and Safety Study of RPT193 in Adults With Atopic DermatitisTerminatedPhase 2RAPT Therapeutics, Inc.NCT05399368Written as RPT193How we know
- Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high AsthmaTerminatedPhase 2RAPT Therapeutics, Inc.NCT05935332Written as RPT193How we know
- A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic DermatitisCompletedPhase 1RAPT Therapeutics, Inc.NCT04271514Written as RPT193How we know
Codes
What other systems call zelnecirnon · ClinicalTrials.gg INT017629
- UNII (FDA) Q0M1LOC2MMZELNECIRNONOne source FDA
- NCI Thesaurus C199020ZelnecirnonOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | Q0M1LOC2MM | ZELNECIRNON | One source FDA |
| NCI Thesaurus | C199020 | Zelnecirnon | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.